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Administration of Peganum harmala extract can be useful in reducing urinary ureteric contractions as a supplementary drug.
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Renal colic is one of the most commonly referred cases of 
emergency ward seen among the people aged 30 to 40 years 
with prevalence of 3 in 1000 every year, which is usually 
described as a severe pain in the flanks that is spread to the 
inguinal region and is associated with nausea and vomiting 
in 50% of people. In the United States, 40% of the people 
refer to the emergency ward for the first time due to the 
renal colic, which has been doubled over the past decade 
(1-3). The prevalence of this disease is in both genders and 
all races, although it is seen more in the African-American 
and Caucasian breeds. Most of the causes of renal colic 
are due to the presence of upper urinary tract stones and 
urinary tract obstruction, and about 80% of the urinary 
tract stones are of calcium oxalate type (2). One of the most 
common causes of ureteral obstruction is the movement 
of stones from the kidneys and their capture in the ureter. 
This discomfort causes severe pain, which is characterized 
by sudden acute pain, nausea, vomiting, pallor, hematuria, 
and change in the color of the urine and, in those who 
have a single kidney, anuria can be mentioned as a sign 
of strangulation of the stone in the ureter (1-3). Although 
the ureteric tissue is without extensive nerve tissue, there 
are several receptors including cholinergic and adrenergic 
receptors on the ureteric tissue, while 70% of which is 
alpha-adrenergic. Alpha-receptors are stimulated by the 
epinephrine and phenylephrine increased contractions, 
and alpha receptor blockers, such as prazosin reduces 
tissue contractions (1-3).
One of the plants that have been considered in traditional 
medicine in Iran for a long time is Peganum harmala. The 
alkaloids of this plant have extensive pharmacological 
effects in various fields such as antispasmodics, anticancer 
effects (4,5), antihistaminic monoamine oxidase inhibitors 
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(6), agonist to receptors such as 5-TH and binding to 
benzodiazepine receptors (7), anti-platelet aggregation 
(8), immunomodulatory effect (9), and also the effect 
of decreasing blood pressure (10). Based on previous 
studies and the similarity of the receptors on the ureter 
and muscle tissue of the prostate, drugs that affect the 
reduction of ureteric contractions can be expected to have 
a similar effect on the contraction of the prostate tissue 
and to reduce the symptoms of the lower urinary system. 
Objectives
The present study was aimed to determine the in vitro 
effect of Peganum harmala extract on human ureteric 
contractions.
Patients and Methods
Preparation of the herbal extract
Peganum harmala was prepared and authenticated by 
expert botanists. A voucher specimen was deposited in 
Herbarium of Medical Plants Research center, Shahrekord 
University of Medical Sciences. The seeds were ground by 
a mechanical grinder. The 70% hydroalcoholic extract was 
prepared using maceration method at room temperature. 
The extract was then filtered and evaporated using 
vacuum rotary evaporator. 
The present study was an experimental-interventional 
study. The studied ureteral tissue was separated from total 
nephrectomy. Uterine tissues have not been involved with 
cancer cells, tissue infection, and abnormal dilatation 
of the ureters. In this experimental study, 28 samples of 
human ureter tissue were studied. Six tissue samples were 
examined for evaluation at concentration of 1 mg/mL, 6 
tissue samples at concentration of 2 mg/mL, and 5 tissues 
at 4 mg/ mL concentration of P. harmala extract. Also, 5 
tissue samples were examined for checking normal saline 
solution and 6 pieces of tissue for checking prazosin 10-8M 
solution. The ureter tissue was removed by nephrectomy 
with any reason, placed in a UW solution at 0°C, and 
immediately transferred to the lab. The ureter was 
separated with the size of one to 2 cm, put in a bath of 
oxygenated Krebs solution at 37°C (pH = 4.7), and then 
placed vertically between two hooks of stainless steel. The 
upper hook was connected to an isometric transducer 
by a thread and then to the physiography device. One 
gram weight on the opposite side of the transducer lever 
hangs on the tissue to make a primitive stretch. Then, 
by adding potassium chloride, the tissue was contracted 
and, after reaching to maximum contraction to examine 
the mechanism of the effect of the extract, was incubated 
with P. harmala, normal saline, and prazosin extracts, and 
the percentage of contraction force changes on paper was 
recorded and calculated. 
Ethical issues 
The research followed the tenets of the Declaration 
of Helsinki. This research was approved by the Ethics 
Committee of Shahrekord University of Medical Sciences. 
(Ethics Committee reference number: IR.SKUMS.
REC.1395.233). Additionally, Shahrekord University 
of Medical Sciences supported this research financially 
(Grant#1462). This study was conducted as the M.D., 
thesis of Arsham Pouriamofrad at this university. 
Statistical analysis 
Data were analyzed by the Prism using descriptive, 
ANOVA, and Tukey tests. P value less than 0.05 was 
considered statistically significant.
Results
In this study, 28 samples of human ureter tissue were 
studied. Six tissue samples were examined for evaluation 
of P. harmala solution at concentration of 1 mg/mL, 6 
tissue samples at concentration of 2 mg/mL, and 5 pieces 
of tissue for evaluation of P. harmala solution at 4 mg/
mL concentration. Also, 5 tissue samples were examined 
for checking NaCl solution and 6 pieces of tissue for 
examination of prazosin solution.
As shown in Table 1, distribution of data using the 
Shapiro-Wilk test, as global, and in terms of the examined 
groups was normal (P < 0.05). ANOVA was used to 
compare contraction between the groups. There was no 
significant difference between the initial contraction 
after adding KCl (P = 0.21), but there was a significant 
difference between the secondary contraction (15 minutes 
after the addition of NaCl, prazosin and P. harmala 
extracts) (P < 0.05).
As shown in Figure 1, two-way ANOVA was used to 
compare the contraction between the groups. Bonferroni 
post analysis showed that there was no significant 
difference between initial tension after adding KCl (P= 
0.21), but there was a significant difference between 
secondary contraction (15 minutes after adding NaCl, 
prazosin and P. harmala) (P < 0.05).
A significant decrease in secondary contraction 
(15 minutes after adding the solution) was observed 
between the prazosin group and the P. harmala group 
at a concentration of 1 mg/mL (P < 0.001). Besides, the 
secondary contraction of the prazosin group showed a 
significant decrease compared with that of the NaCl group 
Table 1. Total values of initial pull (after adding KCl) and secondary 





Contraction after adding 
NaCl, Prazosin and Peganum 
harmala extracts
Prazosin 3.9±0.6 1.08±0.4  
NaCl 4.3±0.7 3.9±0.7
Peganum harmala 4.4±0.5 3.05±0.8
P 0.21 <0.05
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(P < 0.001). However, there was no significant difference 
in the secondary contraction reduction between the P. 
harmala group treated with concentration of 1 mg/mL 
and NaCl group (P = 0.1).
By comparing the secondary contraction (15 minutes 
after addition of KCl solution), there was a significant 
decrease between the prazosin group and the P. harmala 
group at a concentration of 2 mg/mL (P < 0.001). However, 
there was no significant difference in secondary pulling 
reduction between the P. harmala group treated with 
concentration of 2 mg/mL and NaCl group (P = 0.31).
In addition, there was a significant difference in 
the second contraction between the P. harmala group 
treated with concentration of 4 mg/mL and NaCl group 
(P < 0.001). Additionally, a significant difference was 
observed between the prazosin and P. harmala groups 
with a concentration of 4 mg/mL (P = 0.048), which is 
borderline and there is little difference in the secondary 
contraction between the two groups.
Comparing the three groups receiving P. harmala 
extract with concentrations of 1.2 and 4 mg/mL, the 
analysis showed that the response was dose-dependent 
with increasing concentration. There was no significant 
difference between P. harmala group with concentration 
of 1 mg/mL compared with P. harmala group with 
concentration of 2 mg/mL (P < 0.05). A significant 
decrease was observed between P. harmala group with 
concentration of 1 mg/mL compared with P. harmala group 
with concentration of 4 mg/mL (P < 0.001). Meanwhile, 
there was a significant decrease between P. harmala group 
with concentration of 2 mg/mL compared with P. harmala 
group with concentration of 4 mg/mL (P < 0.01). The 
highest reduction in the secondary contraction is related 
to the P. harmala group with a concentration of 4 mg/mL, 
which is very close to the secondary contraction of the 
prazosin group.
Discussion
In the present study, the effects of hydroalcoholic extract 
of Peganum harmala on human ureteric contractions in 
vitro were investigated.
Peganum harmala extract treatment showed a significant 
difference at concentration of 4 mg/mL compared with 
NaCl treatment. The difference in mean secondary 
stretch at 4 mg/mL concentration was significantly lower 
than that of prazosin treatment compared with lower 
concentrations of P. harmala (1 and 2 mg/mL). In fact, the 
effect of P. harmala extract at the concentration of 4 mg/ 
mL was closer to the level of prazosin effect. Depending 
on the dose, the alkaloid derivatives of P. harmala seeds 
(harmine and harmaline) reduce the aortic contractions 
induced by noradrenaline and KCL (11). The aqueous 
extract of P. harmala caused the elimination of the 
jejunum contractions of rabbits and pigs produced by 
acetylcholine (12). Furthermore, another study by Nakada 
et al on smooth muscle of the ureter wall showed that the 
herbal drug doxazosin can reduce the contraction of the 
smooth muscle of the ureter wall, which was also dose-
dependent. Also, the use of doxazosin reduced the effects 
of epinephrine contraction on these muscles (13).
Sukwan et al reported that the ginseng root extract 
(Talinum paniculatum) could significantly prevent self-
contraction of the ureter. This extract also significantly 
inhibited contractions caused by KCl and Oxytocin (14). 
The results of this study were consistent with those of our 
present study.
In the present study, the use of P. harmala extracts, 
especially at a concentration of 4 mg/mL, reduced the 
effect of KCl-induced contraction. Since the main factor 
of contraction of smooth muscle is the presence of 
calcium ions, they can enter the cell through the active 
calcium channels and cause smooth muscle contraction. 
The contraction process continues as long as these 
calcium channels are open. Therefore, the contraction of 
the ureters caused by potassium chloride can be due to 
these channels (15-16).
In the study of Aqel et al, the aqueous extract of P. 
harmala seed had an anti-contractile effect on smooth 
muscles of the intestine, lung, and arteries of rabbits and 
pigs. The researchers said the aqueous extract of P. harmala 
seed had anti-spastic, anticholinergic, antihistamine, and 
anti-adrenergic effects. In their study, the researchers 
reported that the P. harmala seed extract may block the 
calcium ion transfer through voltage-dependent channels 
and receptor-dependent canals and cause anticonvulsant 
effects (12).
It has also been reported that the active compounds of 
P. harmala, such as harmine, harmaline, and harmine, 
showed vasodilatory effects that appear to be related to the 
ability to increase NO production. In addition, quinazoline 
alkaloid and vasicinone isolated from P. harmala seed 
showed relaxant and anti-contractile effects on smooth 
muscle of arteries in mice (12, 17). In the present study, 
the use of P. harmala extract on smooth muscle of the 
ureter had a severe contraction.
In a previous study by Mirzaie et al, hydroalcoholic 
extract of P. harmala at low concentrations increased 
Figure 1. Comparison tension in the primary and secondary groups.
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spontaneous contraction of the uterus muscles and 
decreased the contraction at high concentration of 400 μg/
mL. Reducing muscle contractility at high concentration 
in the present study may be associated with an increase in 
the concentration of inhibitory compounds present in the 
extract which compensate the stimulatory effects at low 
concentrations (18).
Ureteral obstruction induces induction of apoptosis 
in the kidney tissue. It may also lead in the rats to 
interstitial tuberculosis, glomerulosclerosis, infiltration 
of inflammatory cells, and inflammation of the interstitial 
tissue (4); oxidative stress is likely to play a key role in the 
onset and continuation of post-obstruction inflammation, 
resulting in renal tubule injury, interstitial fibrosis, 
necrosis, and apoptosis. Besides, DNA damage increases 
and the mechanisms for its repair decrease. It has also been 
shown that after using antioxidants such as bioflavonoids, 
the damage and oxidative stress as well as the expression 
of apoptotic genes in the obstructed kidney decrease 
(4). Different mechanisms for the protective effect of 
P. harmala and other bioactive compounds in different 
tissues have been proposed (4). On the other hand, the 
antioxidant effects of P. harmala have been proven in 
previous studies. Therefore, it could be suggested that P. 
harmala may also have a protective role against the side 
effects of ureteral obstruction as well as other prostate 
disorders through anti-oxidant effects.
Active compounds of P. harmala are mainly composed 
of alkaloids such as tetrahydroharmine, harmine and 
harmaline (4,19). In addition, Astulla et al observed 
that the P. harmala alkaloids (including harmaline and 
harmine) had anti-plasmodium effects and reduced the 
contractions in the aorta of the mouse (20).
Other alkaloids in P. harmala, such as vasicinone, 
have anti-proliferative properties and can produce cell 
cytotoxicity in tumor cells in a laboratory environment 
(21). Of course, it should not be overlooked that the 
β-carboline alkaloids contained in the P. harmala can 
cause poisoning at high doses (22); hence the use of 
this plant should be done in an effective and non-toxic 
treatment.
Conclusion
In this study, we found the administration of P. harmala 
extract can be useful in reducing urinary human ureteric 
contractions while the best effect was achieved at 4 mg/
mL of P. harmala extract. 
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